Diet Drug-Related Cardiac Valve Disease: The Mayo Clinic Echocardiographic Laboratory Experience
- 1 May 2000
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 75 (5) , 456-461
- https://doi.org/10.4065/75.5.456
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)Published by Elsevier ,2004
- An Assessment of Heart-Valve Abnormalities in Obese Patients Taking Dexfenfluramine, Sustained-Release Dexfenfluramine, or PlaceboNew England Journal of Medicine, 1998
- A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve RegurgitationNew England Journal of Medicine, 1998
- The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant DrugsNew England Journal of Medicine, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Primary pulmonary hypertension and fenfluramine use.Heart, 1993
- Evaluation of aortic insufficiency by Doppler color flow mappingJournal of the American College of Cardiology, 1987
- Color Doppler assessment of mitral regurgitation with orthogonal planes.Circulation, 1987
- Irreversible pulmonary hypertension after treatment with fenfluramine.BMJ, 1986
- Continuous wave doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patientsJournal of the American College of Cardiology, 1985